Sartorius Aktiengesellschaft (SRT3) - Net Assets
Based on the latest financial reports, Sartorius Aktiengesellschaft (SRT3) has net assets worth €3.81 Billion EUR (≈ $4.46 Billion USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€9.61 Billion ≈ $11.24 Billion USD) and total liabilities (€5.80 Billion ≈ $6.78 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check SRT3 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €3.81 Billion |
| % of Total Assets | 39.67% |
| Annual Growth Rate | 16.56% |
| 5-Year Change | 177.98% |
| 10-Year Change | 504.54% |
| Growth Volatility | 22.23 |
Sartorius Aktiengesellschaft - Net Assets Trend (2002–2024)
This chart illustrates how Sartorius Aktiengesellschaft's net assets have evolved over time, based on quarterly financial data. Also explore SRT3 total asset value for the complete picture of this company's asset base.
Annual Net Assets for Sartorius Aktiengesellschaft (2002–2024)
The table below shows the annual net assets of Sartorius Aktiengesellschaft from 2002 to 2024. For live valuation and market cap data, see SRT3 company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €3.90 Billion ≈ $4.56 Billion |
+41.36% |
| 2023-12-31 | €2.76 Billion ≈ $3.22 Billion |
+3.70% |
| 2022-12-31 | €2.66 Billion ≈ $3.11 Billion |
+54.57% |
| 2021-12-31 | €1.72 Billion ≈ $2.01 Billion |
+22.68% |
| 2020-12-31 | €1.40 Billion ≈ $1.64 Billion |
+29.69% |
| 2019-12-31 | €1.08 Billion ≈ $1.26 Billion |
+11.08% |
| 2018-12-31 | €973.39 Million ≈ $1.14 Billion |
+20.68% |
| 2017-12-31 | €806.56 Million ≈ $942.95 Million |
+9.47% |
| 2016-12-31 | €736.80 Million ≈ $861.40 Million |
+14.28% |
| 2015-12-31 | €644.75 Million ≈ $753.78 Million |
+29.71% |
| 2014-12-31 | €497.08 Million ≈ $581.14 Million |
+10.40% |
| 2013-12-31 | €450.25 Million ≈ $526.39 Million |
+11.50% |
| 2012-12-31 | €403.82 Million ≈ $472.11 Million |
+10.33% |
| 2011-12-31 | €366.02 Million ≈ $427.92 Million |
+11.87% |
| 2010-12-31 | €327.18 Million ≈ $382.51 Million |
+2.49% |
| 2009-12-31 | €319.25 Million ≈ $373.23 Million |
-4.24% |
| 2008-12-31 | €333.38 Million ≈ $389.76 Million |
-0.21% |
| 2007-12-31 | €334.10 Million ≈ $390.60 Million |
+97.77% |
| 2006-12-31 | €168.93 Million ≈ $197.50 Million |
+13.87% |
| 2005-12-31 | €148.35 Million ≈ $173.44 Million |
+8.66% |
| 2004-12-31 | €136.53 Million ≈ $159.62 Million |
+5.89% |
| 2003-12-31 | €128.93 Million ≈ $150.73 Million |
-3.70% |
| 2002-12-31 | €133.88 Million ≈ $156.52 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Sartorius Aktiengesellschaft's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 8244.4% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €2.39 Billion | 86.34% |
| Common Stock | €69.00 Million | 2.50% |
| Other Comprehensive Income | €63.90 Million | 2.31% |
| Other Components | €244.90 Million | 8.86% |
| Total Equity | €2.76 Billion | 100.00% |
Sartorius Aktiengesellschaft Competitors by Market Cap
The table below lists competitors of Sartorius Aktiengesellschaft ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
AGCO Corporation
NYSE:AGCO
|
$8.84 Billion |
|
Henan Shijia Photons Technology Co Ltd
SHG:688313
|
$8.85 Billion |
|
Itissalat Al-Maghrib (IAM) S.A
F:MSPA
|
$8.85 Billion |
|
Petronas Gas Bhd
KLSE:6033
|
$8.85 Billion |
|
Fortune Electric Co Ltd
TW:1519
|
$8.84 Billion |
|
DiGi.Com Bhd
KLSE:6947
|
$8.84 Billion |
|
MITSUIO.S.K.LINES ADR/1/2
F:MIL
|
$8.83 Billion |
|
Vanguard International Semiconductor
TWO:5347
|
$8.82 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Sartorius Aktiengesellschaft's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,067,300,000 to 2,764,800,000, a change of 697,500,000 (33.7%).
- Net income of 84,000,000 contributed positively to equity growth.
- Dividend payments of 50,700,000 reduced retained earnings.
- Share repurchases of 198,300,000 reduced equity.
- New share issuances of 198,300,000 increased equity.
- Other comprehensive income increased equity by 82,200,000.
- Other factors increased equity by 582,000,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €84.00 Million | +3.04% |
| Dividends Paid | €50.70 Million | -1.83% |
| Share Repurchases | €198.30 Million | -7.17% |
| Share Issuances | €198.30 Million | +7.17% |
| Other Comprehensive Income | €82.20 Million | +2.97% |
| Other Changes | €582.00 Million | +21.05% |
| Total Change | €- | 33.74% |
Book Value vs Market Value Analysis
This analysis compares Sartorius Aktiengesellschaft's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 5.42x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 111.65x to 5.42x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | €1.95 | €217.20 | x |
| 2003-12-31 | €1.89 | €217.20 | x |
| 2004-12-31 | €2.00 | €217.20 | x |
| 2005-12-31 | €2.18 | €217.20 | x |
| 2006-12-31 | €2.48 | €217.20 | x |
| 2007-12-31 | €4.27 | €217.20 | x |
| 2008-12-31 | €4.25 | €217.20 | x |
| 2009-12-31 | €4.00 | €217.20 | x |
| 2010-12-31 | €4.06 | €217.20 | x |
| 2011-12-31 | €4.50 | €217.20 | x |
| 2012-12-31 | €4.89 | €217.20 | x |
| 2013-12-31 | €5.39 | €217.20 | x |
| 2014-12-31 | €5.84 | €217.20 | x |
| 2015-12-31 | €7.59 | €217.20 | x |
| 2016-12-31 | €8.48 | €217.20 | x |
| 2017-12-31 | €9.03 | €217.20 | x |
| 2018-12-31 | €10.83 | €217.20 | x |
| 2019-12-31 | €11.85 | €217.20 | x |
| 2020-12-31 | €15.31 | €217.20 | x |
| 2021-12-31 | €18.42 | €217.20 | x |
| 2022-12-31 | €29.08 | €217.20 | x |
| 2023-12-31 | €30.22 | €217.20 | x |
| 2024-12-31 | €40.08 | €217.20 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Sartorius Aktiengesellschaft utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.04%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.48%
- • Asset Turnover: 0.33x
- • Equity Multiplier: 3.65x
- Recent ROE (3.04%) is below the historical average (15.91%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 3.35% | 0.93% | 1.20x | 3.00x | €-8.82 Million |
| 2003 | 3.49% | 1.02% | 1.21x | 2.85x | €-8.37 Million |
| 2004 | 11.16% | 3.26% | 1.31x | 2.62x | €1.58 Million |
| 2005 | 14.85% | 4.55% | 1.32x | 2.47x | €7.19 Million |
| 2006 | 17.18% | 5.57% | 1.38x | 2.23x | €12.13 Million |
| 2007 | 10.35% | 5.12% | 0.75x | 2.69x | €1.01 Million |
| 2008 | 5.62% | 2.66% | 0.71x | 2.99x | €-12.69 Million |
| 2009 | 0.36% | 0.16% | 0.73x | 3.01x | €-26.28 Million |
| 2010 | 11.19% | 4.70% | 0.82x | 2.91x | €3.30 Million |
| 2011 | 17.20% | 7.20% | 0.76x | 3.14x | €22.11 Million |
| 2012 | 14.53% | 5.74% | 0.79x | 3.21x | €15.13 Million |
| 2013 | 14.26% | 5.91% | 0.76x | 3.19x | €15.66 Million |
| 2014 | 12.19% | 5.44% | 0.70x | 3.20x | €8.73 Million |
| 2015 | 24.40% | 11.33% | 0.78x | 2.78x | €74.53 Million |
| 2016 | 17.76% | 7.92% | 0.74x | 3.02x | €44.97 Million |
| 2017 | 18.57% | 8.17% | 0.61x | 3.72x | €52.95 Million |
| 2018 | 19.09% | 9.03% | 0.62x | 3.41x | €67.29 Million |
| 2019 | 26.99% | 11.97% | 0.64x | 3.51x | €137.70 Million |
| 2020 | 30.69% | 13.76% | 0.50x | 4.48x | €216.71 Million |
| 2021 | 33.88% | 12.38% | 0.61x | 4.52x | €300.95 Million |
| 2022 | 45.89% | 21.87% | 0.60x | 3.51x | €714.12 Million |
| 2023 | 9.93% | 6.04% | 0.35x | 4.72x | €-1.53 Million |
| 2024 | 3.04% | 2.48% | 0.33x | 3.65x | €-192.48 Million |
Industry Comparison
This section compares Sartorius Aktiengesellschaft's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $5,621,340,699
- Average return on equity (ROE) among peers: -86.39%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Sartorius Aktiengesellschaft (SRT3) | €3.81 Billion | 3.35% | 1.52x | $8.84 Billion |
| SCHOTT Pharma AG & Co. KGaA (1SXP) | $709.04 Million | 17.68% | 0.69x | $2.39 Billion |
| RENAU.UNSP.ARD 1/5 EO-20 (56S0) | $2.51 Billion | 34.85% | 1.01x | $16.46 Billion |
| MEDIMI AB AK (79T) | $332.69K | -959.52% | 4.12x | $427.04K |
| TEVANO SYSTEMS HLDGS INC. (7RBA) | $-1.31 Million | 0.00% | 0.00x | $210.67K |
| STEVANATO GROUP SPA O.N. (87N) | $841.66 Million | 15.96% | 0.69x | $831.06 Million |
| Carl Zeiss Meditec AG (AFX) | $797.45 Million | 7.81% | 0.43x | $2.23 Billion |
| CARL ZEISS MEDITEC ADR 1 (AFXA) | $2.06 Billion | 8.69% | 0.65x | $2.14 Billion |
| Bio-gate AG (BIG1) | $1.55 Million | -51.89% | 1.13x | $5.32 Million |
| COLOPLAST SP.ADR 1/10 DK1 (CBH) | $8.29 Billion | 56.75% | 3.52x | $12.73 Billion |
| ESSILORLUXOTTICA 1/2/O.N. (ESLC) | $41.00 Billion | 5.75% | 0.57x | $93.24 Billion |
About Sartorius Aktiengesellschaft
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management pro… Read more